Jupiter Asset Management LTD Vir Biotechnology, Inc. Transaction History

Jupiter Asset Management LTD

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$9.14 - $24.62 $1.88 Million - $5.07 Million
205,913 Added 40.99%
708,257 $6.64 Million
Q2 2023

Aug 10, 2023
BUY
$23.2 - $27.29 $2.52 Million - $2.97 Million
108,685 Added 27.61%
502,344 $12.3 Million
Q1 2023

May 10, 2023
BUY
$22.26 - $30.85 $8.76 Million - $12.1 Million
393,659 New
393,659 $9.16 Million

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $979M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email